News Focus
News Focus
Followers 6
Posts 515
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Saturday, 10/12/2024 7:46:27 PM

Saturday, October 12, 2024 7:46:27 PM

Post# of 446645
What is ELITE's future revenue potential???
Adderall IR...........$389.8 M
Adderall XR...........$1.56 B
Dantrolene............$6.3 M
Isradipine............$5.5 M
Loxapine..............$5 M
Phendimetrazine.......$4.5 M
Trimipramine..........$2 M
Naltrexone............$16 M
Phentermine Capsules..$7.5 M
Phentermine Tablets...$40 M
Vigabatrin............$233.7 M
Methotrexate..........$63.4M
Current on the market total = $2.334B
Many have not reached full market potential but based on the totals, Elite has approximately 2.5% of the total market for all the above based on FY2024 revenue.
Expect trending UP to over 5% for these in next couple of years = $116.7M

Percocet..............$500 M
Norco.................$477 M
Methadone.............$30 M
Launching SOON market total = $1.007B
Apply the same 2.5% and it will bring Elite an additional $25M in revenue.
Expect trending UP to over 5% for these in next several years = $50.4M in revenue.

Vyvanse...............$5.10 B
Expected approval in November 2024 at the latest and Elite say launch to take priority and as quick as possible.
Apply the same 2.5% and it will bring Elite an additional $127.5M in revenue.

OxyContin.............$720 M
Pending approval and resolving patent case.
Apply the same 2.5% and it will bring Elite an additional $18M in revenue.

So, just estimating revenue growth in FY2025 and following trend same increase from last year you will get $78M for current drugs and then add in those launching and it should be between $90M to $100M.

Now go out two years with currently manufactured drug sales increasing, launched drugs taking off, Vyvanse and Oxy in production and Elite could be generating over $200 MILLION in revenue!!! The above does not include Israel/Dexcel's sales of Adderall, does not include other possibilities with Dexcel, does not include Elite's current development of a generic Concerta, and does not include any other new generics they may be working on.

Just speculating with my limited math skills, lol, but if anyone wants to get out their calculator and correct my math or expand on expectations, PLEASE have at it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News